# Sequential Therapies After Osteoanabolic Treatment

> **NCT06164795** · — · RECRUITING · sponsor: **424 General Military Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **DRUG:** Zoledronate
- **DRUG:** Denosumab
- **DRUG:** Teriparatide
- **DRUG:** Romosozumab
- **DRUG:** Abaloparatide Injection (80 mcg)

## Key facts

- **NCT ID:** NCT06164795
- **Lead sponsor:** 424 General Military Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-25
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164795, "Sequential Therapies After Osteoanabolic Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06164795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*